CAS 414864-00-9
:N-Hydroxy-3-(3-phenylsulfamoylphenyl)acrylamid
- 2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-
- 2-propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-, (2E)-
- Belinostat
- N-Hydroxy-3-(3-phenylsulfamoylphenyl)acrylamide
- N-Hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-2-propenamide
- Pxd101
Rac-Belinostat
CAS:Rac-Belinostat (PX-105684) is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.
Formel:C15H14N2O4SReinheit:99.67% - 99.96%Farbe und Form:SolidMolekulargewicht:318.35Belinostat (PXD-101)
CAS:Kontrolliertes ProduktStability Light Sensitive
Applications Belinostat is a novel histone deacetylase 3 selective inhibitor, which protects the β cells from cytokine-induced apoptosis.
References Chou, D.H., et al.: Chem. Biol., 19, 669 (2012); Hwang, J.J., et al.: Inves. New. Drugs., 30, 1434 (2012); Dizon, D.S., et al.: Gynecol. Oncol., 125, 367 (2012);Formel:C15H14N2O4SFarbe und Form:NeatMolekulargewicht:318.35Belinostat
CAS:Belinostat is a histone deacetylase (HDAC) inhibitor, which is a synthetic compound with a targeted mechanism of action. It is derived from the hydroxamic acid class and functions by inhibiting the activity of HDAC enzymes. These enzymes are responsible for removing acetyl groups from lysine residues on histone and non-histone proteins, altering chromatin structure and affecting gene expression. By inhibiting HDACs, Belinostat leads to an accumulation of acetylated histones, promoting an open chromatin structure and reactivation of silenced genes that can suppress tumor growth.
Formel:C15H14N2O4SReinheit:Min. 95%Molekulargewicht:318.35 g/molRef: 3D-PRA86400
Ausgelaufenes produkt




